Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Verastem Oncology announced that Daniel W. Paterson will retire as President and CEO effective January 1, 2027, and will be succeeded by Michael P. Bailey. Mr. Paterson will remain on the Board of Directors and serve as an advisor, while Mr. Bailey, an existing director with over 30 years of industry experience, will lead the company's next phase of commercial growth.
EastGroup Properties, Inc. announced that newly appointed independent directors Bethany Logan Ropa and Robyn R. Werner have been assigned to the Board's Audit Committee. This filing amends a previous 8-K from October 1, 2026, which initially reported their appointment to the Board following an increase in board size from seven to nine members.
Polar Power, Inc. has appointed Chris Mayer as Co-Chief Executive Officer, effective October 6, 2026, to serve alongside current CEO Arthur D. Sams. Under the new leadership structure, Mayer will oversee corporate strategy, financial performance, and capital markets, while Sams focuses on operations, engineering, and manufacturing. The restructuring is intended to support scalability and growth initiatives in the telecom, data center, and defense industries.
Michael Gathy, Chief Accounting Officer and principal accounting officer of Lazard, Inc., has resigned effective December 11, 2026, to pursue other opportunities. Tracy Farr, the company's current Chief Financial Officer, will assume the additional responsibilities of principal accounting officer upon Gathy's departure.
Brightline Interactive announced the resignation of director Brian Archer, effective at the 2026 annual meeting, and the formalization of CFO William Keneally's compensation through a consulting agreement with CXO Partners. The company will pay CXO a monthly fee of $15,000 for Mr. Keneally's services as CFO. Additionally, the Board reclassified Major General Pete Fesler from a Class I to a Class III director to balance board classes.
Darren W. Woodell, Vice President and Controller (Principal Accounting Officer), notified Genworth Financial of his intent to resign in early November 2026 to pursue a new opportunity. Jerome T. Upton, the company's current CFO, will assume the role of Principal Accounting Officer on an interim basis following Woodell's departure.
Crescent Private Credit Income Corp. announced that Kirill Bouek resigned as Chief Financial Officer effective October 7, 2026. The Board appointed Gerhard Lombard, who currently serves as CFO of Crescent Capital BDC and Crescent Capital Group LP, as the interim Chief Financial Officer. The company stated the resignation was not due to any disagreements regarding operations, policies, or practices.
Sarah Kim notified the Board of Directors of her decision to resign as a director, effective December 31, 2026. Her departure is due to other professional commitments and is not the result of any disagreement with the company regarding its operations, policies, or practices.
Mika Nishimura, a Class II director and Chairperson of the Compensation Committee, has informed the Board of her intention not to stand for re-election at the upcoming 2026 annual meeting of stockholders. Her departure is not due to any disagreement with the company and she will continue to serve until the conclusion of the November 2026 meeting.
Merck & Co., Inc. has elected Paul J. Diaz to its Board of Directors, effective November 1, 2026. Mr. Diaz, a managing partner at Cressey & Company and former CEO of Myriad Genetics and Kindred Healthcare, will serve on the Audit and Research Committees. His appointment increases the Merck board to 14 members ahead of his formal shareholder election in May 2027.
Danaher Corporation increased its Board of Directors to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg as new directors, effective October 9, 2026. Mr. Comas is the company's former CFO, and Dr. Hershberg is the former CEO of HilleVax, Inc. Both will serve until the next annual meeting and participate in the standard non-employee director compensation program.
MetaVia Inc. appointed Sarah Kaplan Browne, M.D. as Chief Medical Officer, effective October 12, 2026. Dr. Browne brings over 20 years of experience in clinical development and regulatory science, specifically in liver and metabolic diseases like MASH. She will lead the clinical strategy for the company's cardiometabolic pipeline, including DA-1726 and vanoglipel.
Saqib Baig, the Chief Accounting Officer and principal accounting officer of Peloton Interactive, Inc., has notified the company of his decision to step down effective November 27, 2026. His departure is to pursue an external opportunity and is not related to any disagreements regarding financial disclosures or accounting matters. The company has initiated a search for a successor.
M Evo Global Acquisition Corp II Leadership Change
M Evo Global Acquisition Corp II appointed Richard Majlinder as a director to its Board, effective October 6, 2026. Mr. Majlinder, who serves as Chief Investment Officer of Maranello Capital, will serve on the Audit and Compensation Committees and has been designated as an audit committee financial expert.
Michael A. Cory is retiring as Executive Vice President and Chief Operating Officer of CSX Corporation, effective October 12, 2026. He will provide transition services through May 8, 2027, under a transition agreement that maintains his $780,000 base salary and eligibility for pro-rated bonuses. Senior Vice Presidents Doug Ryhorchuk and Casey Albright will now report directly to CEO Steve Angel.
Harmony Biosciences announced that Jeffrey M. Dayno, M.D., will retire as President, CEO, and Director effective December 31, 2026. Peter Anastasiou, the company's current Chief Operating Officer and former board member, has been appointed to succeed him as President, CEO, and Director effective January 1, 2027. Dr. Dayno will remain with the company as a non-executive advisor through 2027 to support the transition.
Zoetis Inc. appointed Iris Knobloch to its Board of Directors, effective December 1, 2026, increasing the board size from twelve to thirteen members. Ms. Knobloch, who currently serves as President of the Festival de Cannes and on the boards of Lazard and Vail Resorts, will also serve on the Board’s Corporate Governance Committee.
Mueller Water Products announced that Michael Morgan will succeed Melissa Rasmussen as Chief Financial Officer, effective following the filing of the company's fiscal 2026 Annual Report. Mr. Morgan, who joins from IvyTree Holdings, will initially serve as EVP of Finance starting October 28, 2026, while Ms. Rasmussen will remain as a Senior Advisor through the end of 2026 to ensure a smooth transition.
On October 7, 2026, Board members Laura Huang and David Sherman resigned from the Board of Directors of Nuvve Holding Corp. and all associated committees, effective immediately. Ms. Huang served as chair of the Compensation Committee, while Mr. Sherman served as chair of the Audit Committee.
Sidney Feltenstein, a member of the Board of Directors since 2013, has resigned effective October 30, 2026. The resignation follows a reduction in the beneficial ownership of Ronald N. Tutor's affiliated trusts below the 11.25% threshold required to maintain a board designee under a 2008 Shareholders Agreement.
Bausch + Lomb announced that CEO Brent Saunders has mutually agreed with the Board to depart the company and the Board effective October 12, 2026. Thomas J. Appio, the current Chairman of the Board and CEO of parent company Bausch Health, has been appointed interim CEO. In connection with his departure, Mr. Saunders will receive a $75.5 million lump-sum cash payment and forfeit all outstanding equity awards.
Charter Communications announced that Adam Ray has stepped down as Executive Vice President and Chief Commercial Officer, effective October 12, 2026. Mr. Ray will remain with the company in a non-executive advisory capacity through December 31, 2026, and will receive severance benefits and continued equity vesting in recognition of his 21 years of service.
Evernorth Holdings Inc. appointed Hugo Jeandesboz, formerly of Coinbase Asset Management, as its new Chief Investment Officer to lead the company's XRP treasury strategy. The filing also corrected a clerical error regarding the number of Class A shares issued to PIPE delayed funding subscribers at the closing of its business combination, increasing the count to 1,078,613 shares.
Claire R. McDonough has decided not to stand for re-election to AutoZone's Board of Directors at the upcoming 2026 Annual Meeting of Stockholders. Her departure is due to a scheduling conflict with a new executive role at another company and is not the result of any disagreement with AutoZone's operations or policies.
Brent Pope, the Chief Operating Officer of AgEagle Aerial Systems Inc., notified the company of his intention to retire effective November 30, 2026. The company stated the retirement was not due to any disagreements and it will commence a search for a successor.
Board members Tiffany Norwood and Kelle Wendling resigned from the Board of Directors effective October 6, 2026. Both directors cited disagreements regarding governance, oversight, and management, including the handling of a confidential complaint, which the company explicitly disputes.
Chad Corbin has resigned as Chief Financial Officer of NextBoat Inc. effective October 5, 2026. He will remain in the role during a transition period until a successor is identified, and the company stated his departure was not due to any disagreements regarding operations or policies.
HealthEquity, Inc. terminated the employment of Michael Fiore, the company's Chief Commercial Officer, without cause effective October 5, 2026. His responsibilities will be redistributed among the existing management team, and he will receive severance benefits as outlined in his existing employment agreement.
Quantum Corporation terminated William H. White as Chief Financial Officer and appointed Hiral A. Patel, the current Chief Accounting Officer, as the Principal Financial Officer. Additionally, the company appointed independent directors Yue Zhou White and Donald J. Jaworski to the Audit and Nominating committees, respectively, following the recent resignation of James C. Clancy from the Board.
Mitek Systems announced that Michael E. Diamond, Senior Vice President of Sales, Check Verification, will terminate his employment with the company effective December 8, 2026. The departure is classified as a termination without cause, and Mr. Diamond will receive separation benefits under the company's existing Executive Severance and Change of Control Plan.